BE819515A - Derives de la 4-amino-amphetamine - Google Patents

Derives de la 4-amino-amphetamine

Info

Publication number
BE819515A
BE819515A BE148180A BE148180A BE819515A BE 819515 A BE819515 A BE 819515A BE 148180 A BE148180 A BE 148180A BE 148180 A BE148180 A BE 148180A BE 819515 A BE819515 A BE 819515A
Authority
BE
Belgium
Prior art keywords
amino
amphetamine derivatives
amphetamine
derivatives
Prior art date
Application number
BE148180A
Other languages
English (en)
French (fr)
Inventor
G L Florvall
S B Ross
S-O Ogren
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/xx
Application filed filed Critical
Publication of BE819515A publication Critical patent/BE819515A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
BE148180A 1973-09-04 1974-09-04 Derives de la 4-amino-amphetamine BE819515A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7312001A SE382047B (sv) 1973-09-04 1973-09-04 Forfarande for framstellning av 4-aminoamfetaminderivat

Publications (1)

Publication Number Publication Date
BE819515A true BE819515A (fr) 1975-03-04

Family

ID=20318423

Family Applications (1)

Application Number Title Priority Date Filing Date
BE148180A BE819515A (fr) 1973-09-04 1974-09-04 Derives de la 4-amino-amphetamine

Country Status (16)

Country Link
US (1) US3996381A (no)
JP (1) JPS5835177B2 (no)
AT (1) AT336566B (no)
BE (1) BE819515A (no)
CA (1) CA1051436A (no)
CH (2) CH603547A5 (no)
DE (1) DE2440734C2 (no)
DK (1) DK139716B (no)
FI (1) FI62281C (no)
FR (1) FR2242079B1 (no)
GB (1) GB1461667A (no)
HK (1) HK75778A (no)
IE (1) IE40514B1 (no)
LU (1) LU70852A1 (no)
NL (1) NL7411753A (no)
NO (2) NO139408C (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
JP2004534724A (ja) * 2000-11-01 2004-11-18 センション,インコーポレイテッド 記憶固化を調節するための方法および組成物
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts

Also Published As

Publication number Publication date
CH603547A5 (no) 1978-08-31
JPS5835177B2 (ja) 1983-08-01
NL7411753A (nl) 1975-03-06
DE2440734C2 (de) 1985-01-24
AT336566B (de) 1977-05-10
GB1461667A (en) 1977-01-19
IE40514B1 (en) 1979-06-20
FR2242079B1 (no) 1978-07-21
DE2440734A1 (de) 1975-03-13
FI62281B (fi) 1982-08-31
NO743177L (no) 1975-04-01
DK139716C (no) 1979-09-17
US3996381A (en) 1976-12-07
NO139408B (no) 1978-11-27
DK464774A (no) 1975-05-05
NO142624C (no) 1980-09-17
NO142624B (no) 1980-06-09
CA1051436A (en) 1979-03-27
ATA702574A (de) 1976-09-15
CH599106A5 (no) 1978-05-12
LU70852A1 (no) 1975-06-11
DK139716B (da) 1979-04-02
FR2242079A1 (no) 1975-03-28
NO139408C (no) 1979-03-07
FI62281C (fi) 1982-12-10
NO791507L (no) 1975-03-05
JPS5050329A (no) 1975-05-06
HK75778A (en) 1979-01-05
AU7283374A (en) 1976-03-04
FI257674A (no) 1975-03-05
IE40514L (en) 1975-03-04

Similar Documents

Publication Publication Date Title
BE823812A (fr) Derives de 2-cyclohexene-1-one
BE810511A (fr) Derives de la benzotriazine-1
BE809812A (fr) Derives pyridiniques
BE818648A (fr) Derives polyeniques
BE813002A (fr) Derives polyeniques
BE818487A (fr) Derives de cyclopentane
BE816820A (fr) Derives de la benzoxazolinone
BE823507A (fr) Derives de pyrazole
BE817658A (fr) Derives de camphre
BE810705A (fr) Derives de diazepine
BE822780A (fr) Derives de cepheme
BR7401254D0 (pt) Novos derivados de ftalocianina
BE819515A (fr) Derives de la 4-amino-amphetamine
BE823286A (fr) Derives de la morpholine
BE821484A (fr) Derives de phenoxyethylamine
BE821916A (fr) Derives de (oxo-2 pyridyl-1)-penicilline et -cephalosporine
FR2292476A1 (fr) Derives de la quinoleine
BE822029A (fr) Nouveaux derives de la thiazolyluree
BE814180A (fr) Derives de type piperidino amino-substitues
BE812655A (fr) Derives imidazo-heterocycliques
BE820478A (fr) Derives de substitution de diaza-1
BE818132A (fr) Derives de benzodiazepine
BE818443A (fr) Derives de n-hydroxy-amidine
BE820792A (fr) Derives de la tetrazole-coumarine
BE822807A (fr) Derives de la sysozyme

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ASTRA LAKEMEDEL A.B.

Effective date: 19850930